Article Details
Retrieved on: 2021-12-04 04:06:35
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
“Two doses of ChAd (OxfordUniversity-AstraZeneca) and BNT (Pfizer-BioNTech) have shown 79 per cent and 90 per cent protection, respectively, ...
Article found on: www.thehindubusinessline.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here